Careers

Contact Us

About Us

Home

News

  Introduction      |       Products       |      Applications       |       Partnering       |       Events    

News May 2016: ​​GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma                                        ​More >>

GlycoSeLect Ltd Completes 450K Seed Funding Round​

More >>

News August 2016: ​​GSL UK  Announces Establishment of a New Research Laboratory in South Tees Bio-Incubator                   ​More >>

News Jan 2017: Silicon Republic - Innovation: GlycoSeLect Listed as One of "10 Marvellous Medtec Start-Ups You Need to Know" ​​More >>               

​KBI BioPharma Inc. and Enterprise Ireland Invest in Irish Biotechnology Separations Company, GlycoSeLect Ltd., to Complete its Seed Funding Round

Latest News: October 24th 2017

RPLs present many Advantages over existing analytical and purification tools. RPL production is also readily scalable enabling their use for all application scales.​​

​RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and selective isolation of glycosylated biomolecules. Applications​

GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs). ​​

       Introduction     |        Products        |      Applications      |        Partnering       |      Events 

Recombinant Prokaryotic Lectins